FR23C1045I1 - Composition pour l'utilisation chronique comme composé de prise de poids - Google Patents

Composition pour l'utilisation chronique comme composé de prise de poids

Info

Publication number
FR23C1045I1
FR23C1045I1 FR23C1045C FR23C1045C FR23C1045I1 FR 23C1045 I1 FR23C1045 I1 FR 23C1045I1 FR 23C1045 C FR23C1045 C FR 23C1045C FR 23C1045 C FR23C1045 C FR 23C1045C FR 23C1045 I1 FR23C1045 I1 FR 23C1045I1
Authority
FR
France
Prior art keywords
composition
weight gain
chronic use
compound
gain compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR23C1045C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco Animal Health Inc
Original Assignee
Elanco Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Inc filed Critical Elanco Animal Health Inc
Publication of FR23C1045I1 publication Critical patent/FR23C1045I1/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/132Heterocyclic compounds containing only one nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/184Hormones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/20Feeding-stuffs specially adapted for particular animals for horses
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/14Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/61Growth hormones [GH] (Somatotropin)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/65Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/805Pet food for dog, cat, bird, or fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
FR23C1045C 2015-01-28 2023-11-28 Composition pour l'utilisation chronique comme composé de prise de poids Active FR23C1045I1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562108902P 2015-01-28 2015-01-28
PCT/US2016/015150 WO2016123233A1 (fr) 2015-01-28 2016-01-27 Compositions et procédés pour l'utilisation chronique de composé de prise de poids

Publications (1)

Publication Number Publication Date
FR23C1045I1 true FR23C1045I1 (fr) 2024-01-12

Family

ID=56433115

Family Applications (1)

Application Number Title Priority Date Filing Date
FR23C1045C Active FR23C1045I1 (fr) 2015-01-28 2023-11-28 Composition pour l'utilisation chronique comme composé de prise de poids

Country Status (20)

Country Link
US (2) US9700591B2 (fr)
EP (1) EP3250203B1 (fr)
JP (2) JP6467513B2 (fr)
KR (3) KR20170097212A (fr)
CN (2) CN107205991A (fr)
AR (1) AR103555A1 (fr)
AU (1) AU2016211520B2 (fr)
BR (1) BR112017016078A2 (fr)
CA (1) CA2974012C (fr)
ES (1) ES2902795T3 (fr)
FR (1) FR23C1045I1 (fr)
MX (1) MX2017009435A (fr)
NL (1) NL301251I2 (fr)
NO (1) NO2023044I1 (fr)
NZ (2) NZ733658A (fr)
PL (1) PL3250203T3 (fr)
PT (1) PT3250203T (fr)
RU (1) RU2680410C1 (fr)
TW (2) TWI731241B (fr)
WO (1) WO2016123233A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3037368A1 (fr) * 2016-11-11 2018-05-17 Hill's Pet Nutrition, Inc. Nourriture pour animaux de compagnie comprenant du steviol
US11432776B2 (en) * 2019-06-13 2022-09-06 International Business Machines Corporation Medical device administration and interaction
WO2024173199A1 (fr) * 2023-02-13 2024-08-22 Myos Corp. Traitement pour maladie rénale chronique

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095786A1 (fr) 1992-05-08 1993-11-09 Franco J. Vaccarino Methode de stimulation de l'appetit
EP1181933A3 (fr) 2000-06-29 2002-04-10 Pfizer Products Inc. Utilisation d'un secretagogue de l'hormone de croissance comme comme inducteur de la faim
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
AU2006310690B2 (en) 2005-11-02 2012-05-31 Société des Produits Nestlé S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
CN101541341B (zh) 2006-09-27 2013-06-05 益普生制药两合公司 N末端取代的生长素释放肽类似物
BRPI0807046A2 (pt) * 2007-02-09 2015-05-26 Tranzyme Pharma Inc Composto, composição farmacêutica, métodos de tratar um distúrbio, uma doença cardiovascular e um paciente que sofre de motilidade gastrointestinal reduzida ou disfuncional e, kit.
TWI429436B (zh) 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
RU2007129408A (ru) 2007-07-31 2009-02-10 Игорь Николаевич Жирков (RU) Способ выращивания поросят в период откорма
FR2920295B1 (fr) 2007-09-05 2009-12-11 Desvac Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable
GEP20156222B (en) 2009-03-26 2015-01-26 Takeda Pharmaceutical Pyrazole compound
CA2789750C (fr) * 2010-02-26 2018-03-06 Raqualia Pharma Inc. Agoniste de recepteur de ghreline pour le traitement de la dyscrasie
RU2648958C2 (ru) * 2012-09-27 2018-03-28 Аратана Терапьютикс, Инк. Композиции и способы применения соединения для борьбы с отсутствием аппетита
EP2988616B1 (fr) * 2013-03-15 2018-10-17 Mars, Incorporated Traitement de vomissement idiopathique chronique chez des félins et des chiens

Also Published As

Publication number Publication date
US20160213735A1 (en) 2016-07-28
CN107205991A (zh) 2017-09-26
AU2016211520B2 (en) 2018-07-26
EP3250203B1 (fr) 2021-11-10
AU2016211520A1 (en) 2017-08-03
ES2902795T3 (es) 2022-03-29
KR20170097212A (ko) 2017-08-25
KR20180108916A (ko) 2018-10-04
PL3250203T3 (pl) 2022-04-25
AR103555A1 (es) 2017-05-17
NZ733658A (en) 2018-07-27
KR20180132180A (ko) 2018-12-11
PT3250203T (pt) 2021-11-30
NZ742808A (en) 2024-05-31
CA2974012C (fr) 2020-08-18
KR102256847B1 (ko) 2021-05-27
CN109200268A (zh) 2019-01-15
NO2023044I1 (no) 2023-12-05
TW201636018A (zh) 2016-10-16
JP2019034953A (ja) 2019-03-07
US9700591B2 (en) 2017-07-11
JP6467513B2 (ja) 2019-02-13
TWI674896B (zh) 2019-10-21
BR112017016078A2 (pt) 2018-04-03
NL301251I2 (nl) 2024-03-13
RU2680410C1 (ru) 2019-02-21
EP3250203A4 (fr) 2017-12-06
TWI731241B (zh) 2021-06-21
CA2974012A1 (fr) 2016-08-04
JP7120718B2 (ja) 2022-08-17
US10064909B2 (en) 2018-09-04
MX2017009435A (es) 2017-10-12
US20170281712A1 (en) 2017-10-05
TW201906606A (zh) 2019-02-16
WO2016123233A1 (fr) 2016-08-04
EP3250203A1 (fr) 2017-12-06
JP2018503664A (ja) 2018-02-08

Similar Documents

Publication Publication Date Title
IL269232B (en) Fungicides
SG11202103810VA (en) Substituted tolyl as fungicides
ZA201707424B (en) Novel 5-substituted imidazole derivatives
IL247276A0 (en) [1,2,4]-converted triazole and imidazole compounds as fungicides
HUE049099T2 (hu) Fungicid hatású készítmények
MA42599A (fr) Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides
FR23C1045I1 (fr) Composition pour l'utilisation chronique comme composé de prise de poids
DK3240416T3 (da) Fungicide sammensætninger
CL2016003145A1 (es) Compuestos de [1,2,4]triazol sustituido
IL271604B (en) Fungicides
PL3154949T3 (pl) PODSTAWIONE ZWIĄZKI [1,2,4]TRIAZOLOWE i IMIDAZOLOWE JAKO FUNGICYDY
HK1247788A1 (zh) 殺真菌化合物和組合物
ZA201608472B (en) Substituted [1,2,4]triazole and imidazole compounds as fungicides
PL3724282T3 (pl) Kompozycje zawierające polioksazolinę katalizowane solą oniową
IL267893B (en) Thiobenzoimidazole as fungicides
HRP20190286T1 (hr) Postupci za pripremu spojeva, kao što su 3-arilbutanali, korisni u sintezi medetomidina
HK1221463A1 (zh) 可用作 抑制劑的新型化合物
PT3337322T (pt) Composições fungicidas
IL265578A (en) 5-substituted imidazolylmethyldioxolane derivatives as fungicides
IL265638A (en) 5-substituted imidazolylmethyloxirane derivatives as fungicides
PT3462873T (pt) Composições fungicidas
FR3033711B3 (fr) Structure d'assemblage pour piste-jouet
MC200163B1 (fr) Revêtement pour la protection des supports métalliques
PL3604201T3 (pl) Hydrauliczne oznaczanie masy
ZA201701960B (en) Fungicidal composition